SUSAN PORTER: Open Payments
NPI 1326013129 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$748 in 29 payments from 10 companies in 2025. Trend: 2023 $213 · 2024 $392 · 2025 $748
Food & beverage: $748
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $148 |
| PFIZER INC. | 5 | $116 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $115 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $104 |
| AstraZeneca Pharmaceuticals LP | 4 | $91 |
| Exact Sciences Corporation | 3 | $52 |
| Amgen Inc. | 2 | $50 |
| Merck Sharp & Dohme LLC | 1 | $32 |
| Sumitomo Pharma America, Inc. | 1 | $22 |
| Tris Pharma Inc | 1 | $18 |
Products named: Kerendia, XIFAXAN, NURTEC ODT, Ozempic, Rybelsus, AIRSUPRA, Cologuard Collection Kit, OTEZLA.
Industry payments across MD — which companies pay providers there.
